tiprankstipranks
Cardinal Health (DE:CLH)
FRANKFURT:CLH
Germany Market
CLH
Cardinal Health
RESEARCH TOOLSreports
Want to see DE:CLH full AI Analyst Report?

Cardinal Health (CLH) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

CLH Analyst Ratings

Strong Buy
11Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Cardinal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLH Stock 12 Month Forecast

Average Price Target

€212.92
▲(18.16% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is €212.92 with a high forecast of €228.73 and a low forecast of €199.08. The average price target represents a 18.16% change from the last price of €180.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"120":"€120","229":"€229","147.25":"€147.3","174.5":"€174.5","201.75":"€201.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":228.733308,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€228.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":212.916823332,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€212.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":199.082694,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€199.08</span>\n  </div></div>","useHTML":true}}],"tickPositions":[120,147.25,174.5,201.75,229],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,181.6,185.22563907692307,188.85127815384615,192.47691723076923,196.1025563076923,199.7281953846154,203.35383446153844,206.97947353846155,210.6051126153846,214.23075169230768,217.85639076923076,221.48202984615384,225.10766892307691,{"y":228.733308,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,181.6,184.00898641015385,186.41797282030768,188.82695923046154,191.23594564061537,193.64493205076923,196.0539184609231,198.46290487107692,200.87189128123077,203.2808776913846,205.68986410153846,208.09885051169232,210.50783692184615,{"y":212.916823332,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,181.6,182.94482261538462,184.28964523076922,185.63446784615385,186.97929046153845,188.32411307692308,189.66893569230768,191.0137583076923,192.35858092307691,193.70340353846154,195.04822615384614,196.39304876923077,197.7378713846154,{"y":199.082694,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":125.127,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.074,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.125,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.337,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.205,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.956,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 50, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.798,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 54, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.447,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 44, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.055,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.587,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.414,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":197.415,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€228.73Average Price Target€212.92Lowest Price Target€199.08
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:CLH
Stephen Baxter
Wells Fargo
Wells Fargo
€216.87
Buy
20.35%
Upside
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Evercore ISI Analyst forecast on DE:CLH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
€220.26→€203.32
Buy
12.83%
Upside
Reiterated
04/08/26
Cardinal Health price target lowered to $240 from $260 at Evercore ISICardinal Health price target lowered to $240 from $260 at Evercore ISI
Barclays Analyst forecast on DE:CLH
Glen Santangelo
Barclays
Barclays
―
Buy
―
Reiterated
03/17/26
Analysts' Top Healthcare Picks: Orchestra BioMed Holdings (OBIO), Cardinal Health (CAH)
Deutsche Bank Analyst forecast on DE:CLH
George Hill
Deutsche Bank
Deutsche Bank
―
Hold
―
Reiterated
02/20/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
J.P. Morgan Analyst forecast on DE:CLH
Lisa Gill
J.P. Morgan
J.P. Morgan
€205.86
Hold
14.24%
Upside
Reiterated
02/10/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Quest Diagnostics (NYSE: DGX)
TD Cowen Analyst forecast on DE:CLH
Charles Rhyee
TD Cowen
TD Cowen
€197.39→€212.64
Buy
18.00%
Upside
Reiterated
02/10/26
Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Cardinal Health (NYSE: CAH)
Mizuho Securities Analyst forecast on DE:CLH
Steven Valiquette
Mizuho Securities
Mizuho Securities
€199.08
Buy
10.48%
Upside
Reiterated
02/10/26
Mizuho Securities Keeps Their Buy Rating on Cardinal Health (CAH)
Morgan Stanley Analyst forecast on DE:CLH
Erin Wright
Morgan Stanley
Morgan Stanley
€207.55→€216.03
Buy
19.88%
Upside
Reiterated
02/06/26
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Cardinal Health (NYSE: CAH)
Robert W. Baird Analyst forecast on DE:CLH
Eric Coldwell
Robert W. Baird
Robert W. Baird
€211.79→€213.48
Buy
18.47%
Upside
Reiterated
02/06/26
Cardinal Health price target raised to $252 from $250 at BairdCardinal Health price target raised to $252 from $250 at Baird
UBS Analyst forecast on DE:CLH
Kevin Caliendo
UBS
UBS
€211.79→€220.26
Buy
22.23%
Upside
Reiterated
02/06/26
Cardinal Health price target raised to $260 from $250 at UBSCardinal Health price target raised to $260 from $250 at UBS
Jefferies Analyst forecast on DE:CLH
Brian Tanquilut
Jefferies
Jefferies
€186.38→€228.73
Buy
26.93%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Agios Pharma (NASDAQ: AGIO) and Henry Schein (NASDAQ: HSIC)
Bank of America Securities Analyst forecast on DE:CLH
Allen Lutz
Bank of America Securities
Bank of America Securities
€194.85→€203.32
Buy
12.83%
Upside
Reiterated
01/15/26
Cardinal Health price target raised to $240 from $230 at BofACardinal Health price target raised to $240 from $230 at BofA
Leerink Partners Analyst forecast on DE:CLH
Michael Cherny
Leerink Partners
Leerink Partners
€194.85→€203.32
Buy
12.83%
Upside
Reiterated
01/13/26
Cardinal Health price target raised to $240 from $230 at LeerinkCardinal Health price target raised to $240 from $230 at Leerink
Citi Analyst forecast on DE:CLH
Daniel Grosslight
Citi
Citi
€160.96→€206.71
Buy
14.71%
Upside
Upgraded
01/09/26
Cardinal Health upgraded to Buy from Neutral at CitiCardinal Health upgraded to Buy from Neutral at Citi
Argus Research Analyst forecast on DE:CLH
Steven Silver
Argus Research
Argus Research
€156.72→€160.11
Buy
-11.15%
Downside
Reiterated
08/22/25
Cardinal Health price target raised to $189 from $185 at ArgusCardinal Health price target raised to $189 from $185 at Argus
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:CLH
Stephen Baxter
Wells Fargo
Wells Fargo
€216.87
Buy
20.35%
Upside
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Evercore ISI Analyst forecast on DE:CLH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
€220.26→€203.32
Buy
12.83%
Upside
Reiterated
04/08/26
Cardinal Health price target lowered to $240 from $260 at Evercore ISICardinal Health price target lowered to $240 from $260 at Evercore ISI
Barclays Analyst forecast on DE:CLH
Glen Santangelo
Barclays
Barclays
―
Buy
―
Reiterated
03/17/26
Analysts' Top Healthcare Picks: Orchestra BioMed Holdings (OBIO), Cardinal Health (CAH)
Deutsche Bank Analyst forecast on DE:CLH
George Hill
Deutsche Bank
Deutsche Bank
―
Hold
―
Reiterated
02/20/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
J.P. Morgan Analyst forecast on DE:CLH
Lisa Gill
J.P. Morgan
J.P. Morgan
€205.86
Hold
14.24%
Upside
Reiterated
02/10/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Quest Diagnostics (NYSE: DGX)
TD Cowen Analyst forecast on DE:CLH
Charles Rhyee
TD Cowen
TD Cowen
€197.39→€212.64
Buy
18.00%
Upside
Reiterated
02/10/26
Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Cardinal Health (NYSE: CAH)
Mizuho Securities Analyst forecast on DE:CLH
Steven Valiquette
Mizuho Securities
Mizuho Securities
€199.08
Buy
10.48%
Upside
Reiterated
02/10/26
Mizuho Securities Keeps Their Buy Rating on Cardinal Health (CAH)
Morgan Stanley Analyst forecast on DE:CLH
Erin Wright
Morgan Stanley
Morgan Stanley
€207.55→€216.03
Buy
19.88%
Upside
Reiterated
02/06/26
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Cardinal Health (NYSE: CAH)
Robert W. Baird Analyst forecast on DE:CLH
Eric Coldwell
Robert W. Baird
Robert W. Baird
€211.79→€213.48
Buy
18.47%
Upside
Reiterated
02/06/26
Cardinal Health price target raised to $252 from $250 at BairdCardinal Health price target raised to $252 from $250 at Baird
UBS Analyst forecast on DE:CLH
Kevin Caliendo
UBS
UBS
€211.79→€220.26
Buy
22.23%
Upside
Reiterated
02/06/26
Cardinal Health price target raised to $260 from $250 at UBSCardinal Health price target raised to $260 from $250 at UBS
Jefferies Analyst forecast on DE:CLH
Brian Tanquilut
Jefferies
Jefferies
€186.38→€228.73
Buy
26.93%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Agios Pharma (NASDAQ: AGIO) and Henry Schein (NASDAQ: HSIC)
Bank of America Securities Analyst forecast on DE:CLH
Allen Lutz
Bank of America Securities
Bank of America Securities
€194.85→€203.32
Buy
12.83%
Upside
Reiterated
01/15/26
Cardinal Health price target raised to $240 from $230 at BofACardinal Health price target raised to $240 from $230 at BofA
Leerink Partners Analyst forecast on DE:CLH
Michael Cherny
Leerink Partners
Leerink Partners
€194.85→€203.32
Buy
12.83%
Upside
Reiterated
01/13/26
Cardinal Health price target raised to $240 from $230 at LeerinkCardinal Health price target raised to $240 from $230 at Leerink
Citi Analyst forecast on DE:CLH
Daniel Grosslight
Citi
Citi
€160.96→€206.71
Buy
14.71%
Upside
Upgraded
01/09/26
Cardinal Health upgraded to Buy from Neutral at CitiCardinal Health upgraded to Buy from Neutral at Citi
Argus Research Analyst forecast on DE:CLH
Steven Silver
Argus Research
Argus Research
€156.72→€160.11
Buy
-11.15%
Downside
Reiterated
08/22/25
Cardinal Health price target raised to $189 from $185 at ArgusCardinal Health price target raised to $189 from $185 at Argus
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months
xxx
Success Rate
19/26 ratings generated profit
73%
Average Return
+6.23%
reiterated a xxx
 rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 73.08% of your transactions generating a profit, with an average return of +6.23% per trade.
1 Year
Kevin CaliendoUBS
Success Rate
17/18 ratings generated profit
94%
Average Return
+29.47%
reiterated a buy rating 2 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +29.47% per trade.
2 Years
xxx
Success Rate
17/18 ratings generated profit
94%
Average Return
+69.34%
reiterated a xxx
 rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 94.44% of your transactions generating a profit, with an average return of +69.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLH Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
14
19
30
30
20
Hold
19
16
19
19
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
33
35
49
49
34
In the current month, CLH has received 20 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. CLH average Analyst price target in the past 3 months is 212.92.
Each month's total comprises the sum of three months' worth of ratings.

CLH Financial Forecast

CLH Earnings Forecast

Next quarter’s earnings estimate for CLH is €2.37 with a range of €2.28 to €2.56. The previous quarter’s EPS was €2.23. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s earnings estimate for CLH is €2.37 with a range of €2.28 to €2.56. The previous quarter’s EPS was €2.23. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Sales Forecast

Next quarter’s sales forecast for CLH is €52.73B with a range of €51.29B to €54.56B. The previous quarter’s sales results were €55.73B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s sales forecast for CLH is €52.73B with a range of €51.29B to €54.56B. The previous quarter’s sales results were €55.73B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Stock Forecast FAQ

What is DE:CLH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is 212.92.
    What is DE:CLH’s upside potential, based on the analysts’ average price target?
    Cardinal Health has 18.16% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Cardinal Health a Buy, Sell or Hold?
          Cardinal Health has a consensus rating of Strong Buy, which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Cardinal Health’s share price target?
            The average share price target for Cardinal Health is 212.92. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €228.73 ,and the lowest forecast is €199.08. The average share price target represents 18.16% Increase from the current price of €180.2.
              What do analysts say about Cardinal Health?
              Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Cardinal Health?
                To buy shares of DE:CLH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.